SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
50978 677 3 BTK
Emcee:  Biomaven Type:  Moderated
Biotech stocks are a close second only to internet stocks in how difficult they are to objectively value. This means that biotech stocks can be wildly under- or over-valued, which creates an opportunity for either profit or frustration for an investor that "knows better than market." To paraphrase the master: "Every now and again you should look at the stock price to see if the market is offering to do anything stupid."

This thread grew out of the "Munch-a-Biotech" thread, and is meant to discuss biotech stock valuation methods of all sorts, as well as particular stocks or sectors you may feel are under- or over-valued.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
50978Sooner than later imported (from Asia) API price will increase on its own, due Miljenko Zuanic-yesterday
50977The damage from a 25% tariff on China’s API would be most severe for companies wDewDiligence_on_SI-yesterday
50976<Inasmuch as China is the API source for the large majority of drugs sold in Miljenko Zuanic-yesterday
50975One item that hasn’t received much discussion: Pharmaceuticals—and API—will be oDewDiligence_on_SI-yesterday
50974I noticed general overall strength today in biotech stocks. Is this related to Art Bechhoefer-yesterday
50973This is cool - a mechanism to genetically transmit neuronal information across gnigel bates3June 7
50972Way Off Topic. TED talk by investigative journalist regarding Facebook, CambridA.J. Mullen1June 2
50971Saw your post while doing a search here on NSAIDs. RE exercise and arrhythmia. semi_infinite 3June 1
50970Derek Lowe isn't impressed and i agree lol blogs.sciencemag.orglinhtu-May 31
50969Research confirms gut-brain connection in autism eurekalert.orgbiocqr-May 30
50968The time intervals cited in the iHub AMRN post are not absolute mandates for theDewDiligence_on_SI1May 30
50967AMRN -- Advisory Committee Is the upshot of this IHub post accurate? It's quidditch-May 30
50966If Interested in the GLPG Phase 3 program this paper just out. Dr. Maher I beghmm1May 22
50965There are additional results this weekend. Might as well wait for those. Bad dayJamesK-May 21
50964The Medicines Co up only 2.8% on favorable LT safety, infrequent dosing, and impkeokalani'nui-May 20
50963They both reported results in August 2017 and Fibrogen is now well behind.JamesK-May 19
50962New Long-Term Data Show that Twice-a-Year Dosing with Inclisiran Results in PersA.J. Mullen-May 19
50961MDCO ALNY presented Inclisiran results over the weekend. Seems to be pretty freeJamesK-May 19
50960You gave a couple ideas about why it might be slow to enroll. I thought the trikeokalani'nui-May 18
50959Cryptic...I like it. Still, too little to go on for me. What's your poinatticus4paws-May 18
50958clinicaltrials.gov keokalani'nui-May 18
50957Yes, FGEN's trial will run a little longer and of course start recruiting 3 atticus4paws-May 18
50956Note that the GLPG completion date is more than a year before FGEN.JamesK-May 18
50955Good stuff! Thanks!atticus4paws-May 17
50954I saw press releases calling GLPG's phase 2, a phase 2A. I couldn't findghmm2May 17
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):